Top View
- Manuscript Text (Sequence of Content: Main Text, Methods, Legends [For Figures/Tables], and References)
- Table SI. List of Gout Candidate Genes. A1CF GCKR NIPAL1
- Supplemental Table 3 Two-Class Paired Significance Analysis of Microarrays Comparing Gene Expression Between Paired
- Downregulation of Organic Cation Transporter 1 (SLC22A1) Is Associated with Tumor Progression and Reduced Patient Survival in Human Cholangiocellular Carcinoma
- In Silico Prioritization of Transporter-Drug Relationships From
- Exc-2, an Intermediate Filament Gene, Maintains Tubular Excretory Canals in Caenorhabditis Elegans Along with Ifa-4 and Other Novel Genes
- Elucidation of Substrate Binding Interactions for Human Organic
- Diabetes Medication Associates with DNA Methylation of Metformin Transporter Genes in the Human Liver
- Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: a Special Emphasis on Folding and Trafficking Deficits
- Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity Through Aryl Hydrocarbon Receptor Signaling
- Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR‑2 (SLC19A3) † † † ‡ † § Xiaomin Liang, Huan-Chieh Chien, Sook Wah Yee, Marilyn M
- “The Transporter Transition”
- Variation in the Plasma Membrane Monoamine Transporter (PMAT, Encoded In
- Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology
- Potential Pharmacokinetic Role of Organic Cation Transporters In
- Characterization of Influx Transporters in the Blood-Brain Barrier: Implications for Drug Delivery
- Reduced Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 (OCT1) and Glycaemic Response to Metformin: a Go-DARTS Study
- The Concise Guide to PHARMACOLOGY 2015/16: Transporters
- Downregulation of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in Human Hepatocellular Carcinoma and Their Prog
- 《 Appendix 》 Code No
- Membrane Carriers and Transporters in Kidney Physiology and Disease
- Enhanced and Persistent Inhibition of Organic Cation Transporter 1 (OCT1)
- Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and Hba1c Levels
- Supplementary Table 4. Gene-Set Differential Expression Analysis of TKI Resistance Sample (R2) Versus Pre-TKI Sample (R1) Using Rnaseq Exon Expression Data
- Transcriptomic Changes in the Pre-Implantation Uterus Highlight
- THE CONCISE GUIDE to PHARMACOLOGY 2017/18: Transporters
- The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition
- PMAT) Petra J.M
- Rapid Mendelian Sequencing Gene List December 2018
- Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice During Pregnancy Lyrialle W
- Supplementary Methods To: Cellular Uptake
- Effects of OCT1 Polymorphisms on the Cellular Uptake, Plasma Concentrations and Efficacy of the 5-HT3 Antagonists Tropisetron and Ondansetron
- Membrane Transporters As Mediators of Cisplatin Side-Effects
- Genetic Analysis of SLC47A1, SLC22A1, SLC22A2, ATM Gene Polymorphisms Among Diabetics in an Indian Population